Zhou Rongyao, Pu Liping, Qing Guoping
2024, 33(5):
345-349.
Asbtract
(
26 )
Related Articles |
Metrics
Objective To observe the clinical effect of Shengmaiyin on normal tension glaucoma (NTG) patients with hypotension. Design Non-randomized controlled trial. Participants Thirty patients with NTG with hypotension were divided into two groups, including 17 patients (33 eyes) in the study group and 13 patients (26 eyes) in the control group. Method The study group was treated with reducing intraocular pressure (IOP) eye drops and oral Shengmaiyin (10 ml, tid), while the control group was treated with reducing IOP eye drops only. IOP, blood pressure and visual field were evaluated at the third and sixth months after continuous treatment for 6 months. Visual field index (VFI) improvement or decline of ≥3% was defined as visual field improvement or decline. Main Outcome Measures IOP, systolic blood pressure (SBP), diastolic blood pressure (DBP), ocular perfusion pressure (OPP) and visual field index (VFI). Results The average IOP of the study group and the control group was (13.94±2.23) mmHg and (16.80±2.65) mmHg, respectively. After 3 months and 6 months of treatment, the IOP of the study group was increased by (0.17±0.06) mmHg (P=0.744) and 0.22±0.03 mmHg (P=0.468), respectively. The control group decreased by (0.88±0.25) mmHg (P=0.177) and (1.94±0.81) mmHg (P=0.003), respectively. The values of SBP, DBP and OPP in the study group were higher than those before treatment (P=0.012, 0.006, <0.001, <0.001, <0.001, <0.001). There were significant differences compared with the control group (P=0.049, 0.045, <0.001, <0.001, 0.018, 0.033). After 6 months of treatment, the VFI of 21.21% (7 eyes) in the study group increased by≥3%, 78.79% (26 eyes) showed no change, and the VFI of 0 eyes decreased by≥3%, while that of 0 eyes in the control group increased by≥3%, 96.15% (25 eyes) showed no change, and 3.85% (1 eye) visual field VFI decreased by≥3%. After 6 months of treatment, VFI was significantly different from that before treatment (P=0.012). Conclusion Shengmaiyin can increase arterial blood pressure and ocular perfusion pressure in NTG patients with hypotension, as well as improve visual field index. (Ophthalmol CHN, 2024, 33: 345-349)